We therefore cross-validated the biomarker properties of STAP1 cg04398282 by examining the ROC characteristics using normalized beta values from the PBMC DNA samples which included hepatitis B and hepatitis C patients as well as 29 additional HCC patients that were not included in the T cell DNA methylation analysis (Fig. 6d). This evidence concerns the gene STAP1 and hepatocellular carcinoma.